Leading the Way in Life Science Technologies

GEN Exclusives

More »
GEN News Highlights

Related to Oxyrane Raises $26.5M to Take Lead Enzyme Replacement Therapy Through Phase I/II

Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »